Inventor · disambiguated record
Vivien Wai-Fan Chan
Also filed as: CHAN VIVIEN · CHAN VIVIEN W · CHAN VIVIEN WAI-FAN
15 granted patents·8 pending applications·266 citations·filing 2000–2025
93Inventor score
Files withEUREKA THERAPEUTICS INC9NOVARTIS VACCINES & DIAGNOSTIC5CHIRON CORP3CHAN VIVIEN W2ETTENBERG SETH ALEXANDER1
Top patents by PatentIndex Score
23 records- 0196US7501244B2Determining prognosis of colon or breast cancer by measuring TTK expressionNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Mar 10, 2009·89 cites·21 claims
- 0295US10822389B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·11 cites·22 claims
- 0395US6703221B1Notch receptor ligands and uses thereofCHIRON CORP·Filed 2000·Granted Mar 9, 2004·54 cites·9 claims
- 0494US10464988B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·16 cites·18 claims
- 0594US10098951B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·17 cites·46 claims
- 0693US7279554B2Notch receptor ligands and uses thereofCHIRON CORP·Filed 2003·Granted Oct 9, 2007·33 cites·8 claims
- 0789US7700359B2Gene products differentially expressed in cancerous cellsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Apr 20, 2010·31 cites·9 claims
- 0888US11421013B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Granted Aug 23, 2022·3 cites·20 claims
- 0979US2022348629A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1078US2025361286A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1175US11976105B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·20 claims
- 1268US7501242B2Detection of colon or breast cancer by measuring TTK polynucleotide expressionNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Mar 10, 2009·6 cites·32 claims
- 1365US8299081B2Methods for treating drug resistant cancerMICHELSON GLENN C·Filed 2006·Granted Oct 30, 2012·2 cites·20 claims
- 1464US7501243B2Detection of colon or breast cancer by measuring TTK polypeptide expressionNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Mar 10, 2009·4 cites·31 claims
- 1554US2012308569A1Gene products differentially expressed in cancerous cellsCHAN VIVIEN W·Filed 2012·Application pending·0 cites
- 1652US8221983B2Gene products differentially expressed in cancerous cellsCHAN VIVIEN W·Filed 2010·Granted Jul 17, 2012·0 cites·11 claims
- 1749US7867731B2HX2004-6 polypeptide expressed in cancerous cellsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Jan 11, 2011·0 cites·13 claims
- 1846US2003045491A1TTK in diagnosis and as a therapeutic target in cancerFiled 2002·Application pending·0 cites
- 1944US2010196377A1Methods of treating, diagnosing or detecting cancerJANTAPOUR MARY J·Filed 2007·Application pending·0 cites
- 2042US11274157B2Constructs targeting histone H3 peptide/MHC complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Mar 15, 2022·0 cites·28 claims
- 2139US2020087400A1Constructs targeting psa peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2238US2003186232A1Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereofCHIRON CORP·Filed 2001·Application pending·0 cites
- 2336US2014056912A1Methods of treating squamous cell carcinomaETTENBERG SETH ALEXANDER·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →